This Update No. 4 provides the safety overview of the COVIID-19 vaccine in Ghana for the period 23rd to 29th March 2021. Since publication of Update No. 03 (16th-22nd March 2021)
This Update No. 3 provides the safety overview of the COVIID-19 vaccine in Ghana for the period 16th to 22nd March 2021. Since publication of Update No. 02 (9th-15th March 2021)
From 16th to 19th February 2021, the Volta Regional Office of Food and Drugs Authority (FDA) embarked on a three-day training for health workers in the Oti Region.
The training was held to build capacity for healthcare workers in the early detection of advers.
The Food and Drugs Authority's (FDA) Eastern Regional office organized a public education program at Agartha market in Koforidua on February 16, 2021 to sensitise the public on the position of the Authority on food safety.
As part of the agenda for the progra.
The Food and Drugs Authority (FDA) from the 10th to 12th of February 2021 conducted a meeting to review its 2020 Performance. To ensure strict adherence to the Covid-19 protocols, the APR was held through Microsoft Teams Support, whiles the CEO and some key individua.
This Update No. 2 provides the safety overview of the COVIID-19 vaccine in Ghana for the period 9th to 15th March 2021. Since publication of Update No. 01 (2th-8th March 2021).
The Joint COVID-19 Vaccine Safety Review Committee is an eleven-member independent committee of experts formed to act as a forum of advice to the Food and Drugs Authority on matters relating the post-approval safety monitoring for COVID-19 vaccines and review of all .
The Food and Drugs Authority, (FDA) Ghana, has granted Emergency Use Authorization to two COVID-19 vaccines for use in Ghana; Covishield (Serum Institute of India) and Sputnik V Vaccines (Generium Joint Stock Company, Russia)
The FDA exists to protect public health by assuring the safety, efficacy and security of human and veterinary drugs, food, biological products, cosmetics, medical devices, household chemical substances, tobacco and the conduct of clinical trials in the country.